Literature DB >> 23160195

Extrathymic development of murine T cells after bone marrow transplantation.

Amanda M Holland1, Johannes L Zakrzewski, Jennifer J Tsai, Alan M Hanash, Jarrod A Dudakov, Odette M Smith, Mallory L West, Natalie V Singer, Jessie Brill, Joseph C Sun, Marcel R M van den Brink.   

Abstract

Restoring T cell competence is a significant clinical challenge in patients whose thymic function is severely compromised due to age or cytoreductive conditioning. Here, we demonstrate in mice that mesenteric LNs (MLNs) support extrathymic T cell development in euthymic and athymic recipients of bone marrow transplantation (BMT). Furthermore, in aged murine BMT recipients, the contribution of the MLNs to the generation of T cells was maintained, while the contribution of the thymus was significantly impaired. Thymic impairment resulted in a proportional increase in extrathymic-derived T cell progenitors. Extrathymic development in athymic recipients generated conventional naive TCRαβ T cells with a broad Vβ repertoire and intact functional and proliferative potential. Moreover, in the absence of a functional thymus, immunity against known pathogens could be augmented using engineered precursor T cells with viral specificity. These findings demonstrate the potential of extrathymic T cell development for T cell reconstitution in patients with limited thymic function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160195      PMCID: PMC3533530          DOI: 10.1172/JCI60630

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Clonable progenitors committed to the T lymphocyte lineage in the mouse bone marrow; use of an extrathymic pathway.

Authors:  S Dejbakhsh-Jones; M E Garcia-Ojeda; D Chatterjea-Matthes; D Zeng; S Strober
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Evidence for a stepwise program of extrathymic T cell development within the human tonsil.

Authors:  Susan McClory; Tiffany Hughes; Aharon G Freud; Edward L Briercheck; Chelsea Martin; Anthony J Trimboli; Jianhua Yu; Xiaoli Zhang; Gustavo Leone; Gerard Nuovo; Michael A Caligiuri
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy.

Authors:  C L Mackall; R E Gress
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

4.  Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients.

Authors:  G Dulude; S Brochu; P Fontaine; C Baron; M Gyger; D C Roy; C Perreault
Journal:  Exp Hematol       Date:  1997-08       Impact factor: 3.084

5.  Regulation of extrathymic T cell development and turnover by oncostatin M.

Authors:  C Boileau; M Houde; G Dulude; C H Clegg; C Perreault
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

6.  Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells.

Authors:  M Rincon; R A Flavell
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

Review 7.  Immunological reconstitution following bone marrow transplantation.

Authors:  R Parkman; K I Weinberg
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

8.  Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans.

Authors:  Ineke den Braber; Tendai Mugwagwa; Nienke Vrisekoop; Liset Westera; Ramona Mögling; Anne Bregje de Boer; Neeltje Willems; Elise H R Schrijver; Gerrit Spierenburg; Koos Gaiser; Erik Mul; Sigrid A Otto; An F C Ruiter; Mariette T Ackermans; Frank Miedema; José A M Borghans; Rob J de Boer; Kiki Tesselaar
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

9.  Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Evert-Jan Wils; Bronno van der Holt; Annoek E C Broers; Sandra J Posthumus-van Sluijs; Jan-Willem Gratama; Eric Braakman; Jan J Cornelissen
Journal:  Haematologica       Date:  2011-08-22       Impact factor: 9.941

10.  Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.

Authors:  T N Small; D Avigan; B Dupont; K Smith; P Black; G Heller; T Polyak; R J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  1997-06       Impact factor: 5.742

View more
  10 in total

1.  Making T cells functional: a new solution for the athymic BMT recipients.

Authors:  Wei Sun; Zhuo-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2013-02       Impact factor: 6.150

Review 2.  Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.

Authors:  Christen L Ebens; Ivan Maillard
Journal:  Blood Rev       Date:  2013-08-31       Impact factor: 8.250

Review 3.  Posttransplant chimeric antigen receptor therapy.

Authors:  Melody Smith; Johannes Zakrzewski; Scott James; Michel Sadelain
Journal:  Blood       Date:  2018-01-22       Impact factor: 22.113

4.  Inducible T-cell receptor expression in precursor T cells for leukemia control.

Authors:  S S Hoseini; M Hapke; J Herbst; D Wedekind; R Baumann; N Heinz; B Schiedlmeier; D A A Vignali; M R M van den Brink; A Schambach; B R Blazar; M G Sauer
Journal:  Leukemia       Date:  2015-02-05       Impact factor: 11.528

Review 5.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.

Authors:  Juwita Hübner; Shahabuddin S Hoseini; Julia D Suerth; Dirk Hoffmann; Marcel Maluski; Jessica Herbst; Holger Maul; Arnab Ghosh; Britta Eiz-Vesper; Qinggong Yuan; Michael Ott; Michael Heuser; Axel Schambach; Martin G Sauer
Journal:  Mol Ther       Date:  2016-05-03       Impact factor: 11.454

7.  Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity.

Authors:  Arnab Ghosh; Yildirim Dogan; Maxim Moroz; Amanda M Holland; Nury L Yim; Uttam K Rao; Lauren F Young; Daniel Tannenbaum; Durva Masih; Enrico Velardi; Jennifer J Tsai; Robert R Jenq; Olaf Penack; Alan M Hanash; Odette M Smith; Kelly Piersanti; Cecilia Lezcano; George F Murphy; Chen Liu; M Lia Palomba; Martin G Sauer; Michel Sadelain; Vladimir Ponomarev; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

8.  Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.

Authors:  Nan Wang; Narendiran Rajasekaran; Tieying Hou; Claudia Macaubas; Elizabeth D Mellins
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

9.  Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors.

Authors:  Aishwarya Iyer; Dylan Hennessey; Robert Gniadecki
Journal:  Blood Adv       Date:  2022-04-12

10.  Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals.

Authors:  H-M Yun; J H Oh; J-H Shim; J O Ban; K-R Park; J-H Kim; D H Lee; J-W Kang; Y H Park; D Yu; Y Kim; S B Han; D-Y Yoon; J T Hong
Journal:  Cell Death Dis       Date:  2013-05-23       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.